“ We are excited to share the novel intelligence and predictive power of AMI by partnering with healthcare providers and innovators to drive precision medicine across healthcare.”
Applied Morphomics, Inc. (AMI) is a privately-held company, founded in 2017 by Stewart C. Wang, M.D., Ph.D. to develop technology discovered at the University of Michigan. AMI’s mission is to make the next generation of digital biomarker technology, essential for delivering precision medicine, available to the greater healthcare community.
Take a look inside our founder’s lab — Morphomic Analysis Group at the University of Michigan.
AMI headquarters in Ann Arbor is located adjacent to the University of Michigan campus and 25 miles from Detroit Metropolitan Airport.
Reach the AMI team here: